We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Biomet Spine 483 Relates to Validation Records, Complaints

Biomet Spine 483 Relates to Validation Records, Complaints

January 20, 2015

FDA investigators handed Biomet Spine a four-observation Form 483 for deficiencies with validation records and complaint-handling problems.

A protocol at the Broomfield, Colo., facility set certain acceptance criteria for microbial contamination of water produced by a system. But reports documented in the lab exceeded the acceptance criteria and Biomet Spine did not investigate the elevated microbial counts. Instead, the devicemaker changed the acceptance criteria in the report, according to the form.

Another observation relates to Biomet Spine’s handling of a complaint that documented a patient death during a procedure using a Timberline retractor to remove an artificial disc. According to the complaint record, the sales representative indicated the retractor did not contribute to the death. But there was no documentation of information supporting this statement from a person qualified to make a medical judgment, the form says. And Biomet Spine did not report the death to the FDA as an MDR.

The company also failed to report a recall of 120 Durango Anchored Anterior Lumbar Interbody Fusion Plate Sets following two complaints of set screws dislodging from the plates.
Biomet Spine did not return a request for comment by press time.

To avoid 483s like this, you need a systemwide solution — one that turns your entire operation into a well-oiled complaint-handling machine. So purchase Secrets of Medical Device Complaint Management: A Guide for Compliance now!

Devices Inspections and Audits

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Wesper Next-Generation Device Cleared for Sleep Test Data Collection

  • FDA Approves First-Ever Treatment for Activated Phosphoinositide 3-Kinase Delta Syndrome

  • FemDx Medsystems Falloposcope Cleared

  • Cyclerion’s Mitochondrial Diseases Candidate Gets Orphan Drug Nod

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing